These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 14971349)

  • 1. New drug for women with irritable bowel syndrome.
    Mayo Clin Health Lett; 2003 Dec; 21(12):4. PubMed ID: 14971349
    [No Abstract]   [Full Text] [Related]  

  • 2. New drug approved for irritable bowel syndrome in women.
    Mayo Clin Womens Healthsource; 2004 Feb; 8(2):3. PubMed ID: 14722489
    [No Abstract]   [Full Text] [Related]  

  • 3. Tegaserod in patients with irritable bowel syndrome.
    Schooff M; Stelter C
    Am Fam Physician; 2004 Dec; 70(11):2107-8. PubMed ID: 15606056
    [No Abstract]   [Full Text] [Related]  

  • 4. Review article: tegaserod -- the global experience.
    Chey WD
    Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 7():15-9. PubMed ID: 15521850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. By the way, doctor. I have irritable bowel syndrome, with frequent bloating and constipation. My doctor prescribed a six-week course of Zelnorm, which really helped. Is it safe to take long-term?
    Robb-Nicholson C
    Harv Womens Health Watch; 2005 May; 12(9):8. PubMed ID: 16047399
    [No Abstract]   [Full Text] [Related]  

  • 6. [Tegaserod in treatment of women with irritable bowel syndrome].
    Munck LK; Ainsworth MA
    Ugeskr Laeger; 2007 Jun; 169(23):2190-2. PubMed ID: 17592683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irritable bowel syndrome.
    Kennedy T; Rubin G; Jones R
    Clin Evid; 2004 Jun; (11):615-25. PubMed ID: 15652025
    [No Abstract]   [Full Text] [Related]  

  • 8. A response to Farup and Bytzer. Tegaserod Nordic trial.
    Nyhlin H; Hunt R
    Scand J Gastroenterol; 2004 Aug; 39(8):803-4. PubMed ID: 15513374
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of tegaserod on work and daily activity in irritable bowel syndrome with constipation.
    Reilly MC; Barghout V; McBurney CR; Niecko TE
    Aliment Pharmacol Ther; 2005 Sep; 22(5):373-80. PubMed ID: 16128674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FDA approves one drug for irritable bowel syndrome but suspends another.
    Harv Womens Health Watch; 2008 Aug; 15(12):7. PubMed ID: 19115501
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of a laxative with and without tegaserod in adolescents with constipation predominant irritable bowel syndrome.
    Khoshoo V; Armstead C; Landry L
    Aliment Pharmacol Ther; 2006 Jan; 23(1):191-6. PubMed ID: 16393297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tegaserod is effective in the initial and retreatment of irritable bowel syndrome with constipation.
    Müller-Lissner S; Holtmann G; Rueegg P; Weidinger G; Löffler H
    Aliment Pharmacol Ther; 2005 Jan; 21(1):11-20. PubMed ID: 15644040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of withdrawing tegaserod treatment in comparison with continuous treatment in irritable bowel syndrome patients with abdominal pain/discomfort, bloating and constipation: a clinical study.
    Bardhan KD; Forbes A; Marsden CL; Mason T; Short G
    Aliment Pharmacol Ther; 2004 Jul; 20(2):213-22. PubMed ID: 15233702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Motility disorders. Abnormal gastrointestinal muscle contractions.
    Mayo Clin Health Lett; 2004 Apr; 22(4):6. PubMed ID: 15101342
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug treatment for irritable bowel syndrome].
    Hillilä M; Färkkilä M
    Duodecim; 2004; 120(20):2453-8. PubMed ID: 15641514
    [No Abstract]   [Full Text] [Related]  

  • 16. Tegaserod for constipation-predominant irritable bowel syndrome.
    Kale-Pradhan PB; Wilhelm SM
    Pharmacotherapy; 2007 Feb; 27(2):267-77. PubMed ID: 17253916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the constipated Asian male more common than we think?
    Gwee KA; Wong RK
    J Gastroenterol Hepatol; 2007 Aug; 22(8):1168-9. PubMed ID: 17688656
    [No Abstract]   [Full Text] [Related]  

  • 18. Desperately seeking serotonin... A commentary on the withdrawal of tegaserod and the state of drug development for functional and motility disorders.
    Pasricha PJ
    Gastroenterology; 2007 Jun; 132(7):2287-90. PubMed ID: 17570201
    [No Abstract]   [Full Text] [Related]  

  • 19. New drug for bothersome bowels.
    Health News; 2000 Apr; 6(4):8. PubMed ID: 15356893
    [No Abstract]   [Full Text] [Related]  

  • 20. Meta-analysis: The treatment of irritable bowel syndrome.
    Lesbros-Pantoflickova D; Michetti P; Fried M; Beglinger C; Blum AL
    Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1253-69. PubMed ID: 15606387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.